Goldman Sachs’s AN2 Therapeutics ANTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-224,185
| Closed | -$482K | – | 4825 |
|
|
2024
Q2 | $482K | Buy |
224,185
+195,815
| +690% | +$421K | ﹤0.01% | 3977 |
|
|
2024
Q1 | $92.2K | Buy |
28,370
+14,324
| +102% | +$46.6K | ﹤0.01% | 4470 |
|
|
2023
Q4 | $288K | Buy |
+14,046
| New | +$288K | ﹤0.01% | 4206 |
|
|
2023
Q3 | – | Sell |
-39,107
| Closed | -$332K | – | 4724 |
|
|
2023
Q2 | $332K | Buy |
+39,107
| New | +$332K | ﹤0.01% | 4185 |
|
|
2022
Q2 | – | Sell |
-19,497
| Closed | -$294K | – | 5682 |
|
|
2022
Q1 | $294K | Buy |
+19,497
| New | +$294K | ﹤0.01% | 4893 |
|